Floatz logo

110 assets in Gastroesophageal Junction Adenocarcinoma

Therapeutic assets addressing Gastroesophageal Junction Adenocarcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
XYA02
Gastroesophageal Junction Adenocarcinoma
XYone Therapeutics, IncP1/2CC (47)
Cabotamig
Gastroesophageal Junction Adenocarcinoma
Arbele Pty LtdP1CC (46)
Zanidatamab
Gastroesophageal Junction Adenocarcinoma
Boehringer IngelheimP1/2CC (46)
1H-Isoindol-1-one, 2,3-dihydro-2-[3-[cis-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl]-6-[[(3S)-3-methyl-1-piperidinyl]methyl]-4-(trifluoromethyl)-
Gastroesophageal Junction Adenocarcinoma
Nurix Therapeutics, Inc.P1CC (43)
ai-061
Gastroesophageal Junction Adenocarcinoma
OncoC4, Inc.P1CC (43)
asp2138
Gastroesophageal Junction Adenocarcinoma
Astellas Pharma Global Development, Inc.P1CC (43)
Autologous Genetically Modified Mage-A4ᶜ¹º³²T Cells
Gastroesophageal Junction Adenocarcinoma
USWM CT, LLCP1CC (43)
ava6103
Gastroesophageal Junction Adenocarcinoma
Avacta Life Sciences LtdP1CC (43)
Azenosertib
Gastroesophageal Junction Adenocarcinoma
National Cancer Institute (NCI)P1CC (43)
Bgb-53038
Gastroesophageal Junction Adenocarcinoma
BeOne MedicinesP1CC (43)
Bl-M07D1
Gastroesophageal Junction Adenocarcinoma
SystImmune Inc.P1CC (43)
Bl-M17D1
Gastroesophageal Junction Adenocarcinoma
SystImmune Inc.P1CC (43)
bnt141
Gastroesophageal Junction Adenocarcinoma
BioNTech SEP1/2CC (43)
Ceralasertib
Gastroesophageal Junction Adenocarcinoma
National Cancer Institute (NCI)P1CC (43)
Cetuximab
Gastroesophageal Junction Adenocarcinoma
BeOne MedicinesP1CC (43)
ct041 autologous car t-cell
Gastroesophageal Junction Adenocarcinoma
CARsgen Therapeutics Co., Ltd.P1/2CC (43)
dr-0202
Gastroesophageal Junction Adenocarcinoma
Dren BioP1CC (43)
Elimusertib
Gastroesophageal Junction Adenocarcinoma
National Cancer Institute (NCI)P1CC (43)
Gotistobart
Gastroesophageal Junction Adenocarcinoma
OncoC4, Inc.P1/2CC (43)
iks014
Gastroesophageal Junction Adenocarcinoma
Iksuda Therapeutics Ltd.P1CC (43)
Ipilimumab
Gastroesophageal Junction Adenocarcinoma
Neonc Technologies, Inc.P1/2CC (43)
lb1908
Gastroesophageal Junction Adenocarcinoma
Legend Biotech USA IncP1CC (43)
MDG1015
Gastroesophageal Junction Adenocarcinoma
Medigene AGP1CC (43)
neo212
Gastroesophageal Junction Adenocarcinoma
Neonc Technologies, Inc.P1/2CC (43)
Nrm-823
Gastroesophageal Junction Adenocarcinoma
Normunity AccelCo, Inc.P1CC (43)
pf-07265028
Gastroesophageal Junction Adenocarcinoma
PfizerP1CC (43)
Plx-61639
Gastroesophageal Junction Adenocarcinoma
Plexium, Inc.P1CC (43)
Regorafenib
Gastroesophageal Junction Adenocarcinoma
Neonc Technologies, Inc.P1/2CC (43)
Rndo-564
Gastroesophageal Junction Adenocarcinoma
Rondo TherapeuticsP1CC (43)
Sgn-Alpv
Gastroesophageal Junction Adenocarcinoma
Seagen Inc.P1CC (43)
Sysa1801 For
Gastroesophageal Junction Adenocarcinoma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.P1CC (43)
Talazoparib
Gastroesophageal Junction Adenocarcinoma
Roswell Park Cancer InstituteP1CC (43)
Tipiracil
Gastroesophageal Junction Adenocarcinoma
Roswell Park Cancer InstituteP1CC (43)
tj033721
Gastroesophageal Junction Adenocarcinoma
I-Mab Biopharma US LimitedP1CC (43)
Trastuzumab Emtansine
Gastroesophageal Junction Adenocarcinoma
Boehringer IngelheimP1/2CC (43)
Trifluridine
Gastroesophageal Junction Adenocarcinoma
Roswell Park Cancer InstituteP1CC (43)
xnw27011
Gastroesophageal Junction Adenocarcinoma
Evopoint Biosciences Inc.P1/2CC (43)
Zongertinib
Gastroesophageal Junction Adenocarcinoma
Boehringer IngelheimP1/2CC (43)
Durvalumab
Gastroesophageal Junction Adenocarcinoma
I-Mab Biopharma US LimitedP1CC (42)
Sigvotatug Vedotin
Gastroesophageal Junction Adenocarcinoma
Seagen, a wholly owned subsidiary of PfizerP1CC (42)
Zimberelimab
Gastroesophageal Junction Adenocarcinoma
Arcus Biosciences, Inc.P1CC (42)
177lu-dota-sna040
Gastroesophageal Junction Adenocarcinoma
SmartNuclide BiopharmaEarly P1C (39)
[68ga]ga-nodaga-sna014
Gastroesophageal Junction Adenocarcinoma
SmartNuclide BiopharmaEarly P1C (39)
Acc-1898
Gastroesophageal Junction Adenocarcinoma
AccSalus Biosciences, Inc.P1C (39)
Atezolizumab
Gastroesophageal Junction Adenocarcinoma
ExelixisP1C (39)
Cabozantinib
Gastroesophageal Junction Adenocarcinoma
ExelixisP1C (39)
Claudin 18.2 Car-T
Gastroesophageal Junction Adenocarcinoma
Suzhou Immunofoco Biotechnology Co., LtdP1C (39)
ct048 autologous
Gastroesophageal Junction Adenocarcinoma
Peking UniversityP1C (39)
im92 car-t cells
Gastroesophageal Junction Adenocarcinoma
Beijing Immunochina Medical Science & Technology Co., Ltd.Early P1C (39)
kk2269
Gastroesophageal Junction Adenocarcinoma
Kyowa Kirin Co., Ltd.P1C (39)
Showing 51 to 100 of 110 assets
PreviousPage 2 of 3Next